Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin for Left Ventricular Mass in Type 2 Diabetes and CAD
NCT01863147Phase 4Completed
- Sponsor
- General Hospital of Central Theater Command of the Chinese People's Liberation Army
- Start
- Jul 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by General Hospital of Central Theater Command of the Chinese People's Liberation Army. Started Jul 2013; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01863147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01863147.